Vein Occlusion: A Multi-Approach Comparative Study Using PRP Alone vs  Combined PRP + New Anti-VEGF Therapy

Fareeha Mirza, Adeel Chaudhry, Omar Ishtiaq³ Muhammad Imran Ali, Fakhar Humayun, Junaid Afsar Khan, Ali Amer

Vein Occlusion: A Multi-Approach Comparative Study Using PRP Alone vs Combined PRP + New Anti-VEGF Therapy

Authors

Fareeha Mirza, Adeel Chaudhry, Omar Ishtiaq³ Muhammad Imran Ali, Fakhar Humayun, Junaid Afsar Khan, Ali Amer

Abstract

This prospective comparative study evaluated the efficacy of panretinal photocoagulation (PRP)alone versus PRP plus aflibercept (a newer anti-VEGF agent) in two vision-threatening retinal vascular diseases: proliferative diabetic retinopathy

References

Brown, D. M., et al. (2023). Aflibercept for the management of diabetic macular edema: 24-month results. Ophthalmology,https://doi.org/10.1016/j.ophtha.2022.09.017 130(3),

–245.

Campochiaro, P. A., et al. (2022). Comparison of aflibercept and ranibizumab in diabetic macular edema: A randomized controlled trial. JAMA Ophthalmology, 140(2), 123–130. https://doi.org/10.1001/jamaophthalmol.2021.5504

Downloads

Published

2025-09-23

How to Cite

Fareeha Mirza, Adeel Chaudhry, Omar Ishtiaq³ Muhammad Imran Ali, Fakhar Humayun, Junaid Afsar Khan, Ali Amer. (2025). Vein Occlusion: A Multi-Approach Comparative Study Using PRP Alone vs Combined PRP + New Anti-VEGF Therapy . International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 2201–2207. Retrieved from https://ijprt.org/index.php/pub/article/view/1032